A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth

H Iwamoto1, M Nakamuta, S Tada

  • 1Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan. gann@intmed3.med.kyushu-u.ac.jp

Journal of Hepatology
|June 14, 2000
PubMed
Abstract

Insights

Y-27632, a p160ROCK inhibitor, blocks hepatic stellate cell (HSC) activation and collagen production. This suggests RhoA-ROCK pathway inhibitors may treat liver fibrogenesis.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Hepatology

Background:

  • p160ROCK is a serine/threonine protein kinase and a direct RhoA target.
  • Rho signaling pathways are crucial in activating rat hepatic stellate cells (HSC).

Purpose of the Study:

  • To investigate the mechanism of action of the p160ROCK-specific inhibitor Y-27632 on cultured rat HSC.
  • To explore the role of the RhoA-ROCK pathway in hepatic fibrogenesis.

Main Methods:

  • HSC isolation and culture on fibronectin-coated dishes.
  • Microscopy for cell morphology and actin cytoskeleton analysis.
  • Immunoblotting for protein phosphorylation and cell cycle markers.
  • Assays for cell proliferation, collagen gene expression, and protein accumulation.

Main Results:

  • Y-27632 inhibited HSC cell spreading, stress fiber formation, and focal adhesion kinase/extracellular signal-regulated kinase phosphorylation.
  • Y-27632 blocked HSC proliferation by affecting cyclin D1 and p27 levels.
  • Y-27632 reduced type I collagen gene expression and accumulation.

Conclusions:

  • p160ROCK-mediated actin stress fiber assembly is implicated in hepatic fibrogenesis.
  • Inhibitors of the RhoA-ROCK pathway show potential therapeutic value for liver fibrogenesis.

Related Concept Videos